Kadian™ capsules are a sustained release oral formulation of morphine sulphate indicated for the management of moderate to severe chronic pain.
Kadian's™ drug delivery profile is achieved with Mayne Pharma’s sustained release pellet technology. This provides patients with smooth steady-state plasma levels for consistent pain relief.
Kadian™ capsules may be dosed once or twice daily to maintain therapeutic blood levels and is available in a number of flexible modes of administration (capsules, sprinkle and G-tube) and doses (10mg, 20mg, 50mg and 100mg in Australia, Canada and various other international territories).
Kadian™ capsules are currently licensed to Abbott Laboratories (as Kadian™) and Dainippon (as Kadian™) and sold in Australia, Canada and Japan and various other international territories. Further licensing opportunities remain.
This product is prescription only. Your doctor will advise you whether this product is suitable for you. Always read the label. Use only as directed. If symptoms persist see your health care professional.